Skip to main content

Table 1 Molecular findings and multiorgan characteristics

From: Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment

Patient/Sex

1 Male

2 Female

3 Female

4 Male

5 Male

6 Female

7 Female

8 Male

9 Female

10 Female

11 Female

12 Female

13 Male

Molecular findings

p.E93A/p.R141H

p.R123Q/p.C241S

p.F157S/p.C241S

p.L32R/p.R141H

p.R162W/c.523 + 3A > G

p.F157S/p.R162W

p.P113L/p.D209G

p.C241S/p.R141H

p.T237M/c.640-9 T > G

p.P113L/c.353C > T + c.550C > A

p.R123X/p.I153T

p.P113L/p.P113L

p.E139K/ p.E139K

Age at evaluation/age at onset

15 years/21 months

6 years/9 months

8 years/8 months

7 years/Newborn

10 years/3 months

10 years/8 months

11 years/Newborn

5 years/2.5 years

11 years/8 months

8 years/7 months

16 years/Newborn

6 years/3 months

11 years/ Newborn

Dysmorphic features

Large normal setting ears

Almond slanted eyes

No

Anteverted ears

Inverted nipples

Lipodystrophy

Almond slanted eyes, lipodystrophy

No

Almond slanted eyes

Almond slanted eyes, low anteverted ears, lipodystrophy

Almond slanted eyes, thick lips, pronounced cheekbones, lipodystrophy

Almond slanted eyes, broad face, large mouth, lipodystrophy,

Almond slanted eyes, broad face, large mouth, lipodystrophy

Cardiac involvement

No

No

No

No

No

No

No

No

No

No

No

PDA

Truncus arteriosus

Digestive involvement

Diarrhea, hypoglycemia

No

No

Vomits

No

↑ALT

↑ALT, AST (only perinatal period)

No

↑ALT, AST

Growth failure, hypoglycemia

Vomits, growth failure, diarrhea

↑ALT, AST

Failure to drive

Coagulation

↓ AT-III, PC

↓ AT-III, PC, PS

↓ AT-III, PC

↓ AT-III, PC

Normal

↑ PT; ↓AT-III, PS

↓ PC, PS

No

↓FXI

↑PT, aPTT,

↓ aPTT

↓ AT-III

↑PT

↓AT-III, PC, PS

Endocrine involvement

No

No

No

No

No

No

Hypergonadotropic hypogonadism

No

No

Mild ↑TSH, hypoglycemia

Delayed puberty

ND

No

Kidney involvement

Nephro calcinosis

No

No

No

No

No

No

No

No

↑Echogenicity, nephrolithiasis

Proteinuria

No

No

Eye abnormalities

Strabismus, pigmentary retinopathy

Strabismus upgaze deviation

Strabismus

Strabismus, hypermetropia, astigmatism

Strabismus, saccadic movements hypermetropia

Strabismus, hypermetropia

Strabismus, hypermetropia, astigmatism, abnormal ERG

No

Strabismus

Strabismus, upgaze deviation, saccadic movements

Strabismus, upgaze deviation, retinopathy, hypermetropia

Strabismus, hypermetropia

Strabismus

  1. PDA Persistent ductus arteriosus, ALT Alanine transaminase, AST Aspartate transaminase, ↑ Increased values, ↓ Decreased values, AT-III Antithrombin III, PC Protein C, PS Protein S, FXI Coagulation factor XI, aPTT Activated partial thromboplastin time, FIX Coagulation factor IX, PT Prothrombin time, ND No data available, TSH Thyroid stimulating hormone